Artículos sobre Alzheimer
Artículos científicos publicados por los investigadores del Barcelonaβeta Brain Research Center (BBRC), relacionados con la enfermedad de Alzheimer, neuroimagen, memoria y enfermedades neurodegenerativas, entre otros campos.
-
Álvarez-Bustos A, Andres-Lacueva C, Ara I, Arévalo MA, Bolaños JP, Coto-Montes A, Enriquez JA, Escames G, García-García FJ, Gómez-Cabrera MC, Grau-Rivera O, Izquierdo M, Martínez Velilla N, Matheu A, Menéndez Colino R, Muñoz Torres M, Nogués X, Oliva J, Orts-Cortés MI, Párraga Martínez I, Priego F, Rabassa-Bonet M, Rol MÁ, Serra-Rexach JA, Tarazona-Santabalbina FJ, Rodríguez-Mañas L, Abizanda P
Consensus document on frailty: conceptualization, detection, multidisciplinary management and future roadmap
The Journal of NutritionAbstractBackground: The lack of a universally accepted definition, a gold-standard assessment tool, and sufficient evidence-based interventions has hindered the integration of frailty into routine clinical...
-
Vilor-Tejedor N, Danso S, Albanus RD, Billingsley K, Evans TE, Lee LY, Wang S, Jiang J, Liu H, Ross J, Chilla G
Advancing global dementia research through equity and inclusion
Alzheimer's & DementiaAbstractDespite the global burden of dementia, research remains dominated by high-income, Western populations, limiting the generalizability and equity of findings. In this Perspective, we highlight the...
-
Magumba K, Piletska E, Cao TH, Jones D, Macip S, Piletsky S.
Molecularly Imprinted Polymer Nanoparticles for Lung-Cancer-Cell-Surface Proteomics
PolymersAbstractThe identification and targeting of lung-cancer-cell-surface proteins are important for drug development. Molecularly imprinted polymer nanoparticles (nanoMIPs) offer a synthetic approach for the...
-
Genius P, Rodríguez-Fernández B, Minguillon C, Brugulat-Serrat A, Huguet J, Esteller M, Sudre CH, Cortés Canteli M, Tristão-Pereira C, García Lunar I, Navarro A, Gispert JD, Vilor-Tejedor N.
Polygenic risk for white matter hyperintensities is associated with early cerebrovascular events partly through hemodynamic measures in cognitively unimpaired middle-aged and older adults with low cardiovascular risk
Frontiers in NeurologyAbstractBackground: White matter hyperintensities (WMH) are a hallmark of cerebrovascular disease. They are often found in middle-aged individuals and are associated with a greater risk of stroke and vascular...
-
Lázaro I, Luján-Barroso L, Soldevila-Domenech N, Amor AJ, Ortega E, Ros E, Sánchez MJ, Rodríguez-Barranco M, Guevara M, Moreno-Iribas C, Schröder H, Fitó M, Tintle NL, Ryder N, Harris WS, Agudo A, Sala-Vila A
Development of a blood-based lipidomic fat quality score for the risk of ischemic stroke
European stroke journalAbstractIntroduction: Poor-quality diets promote ischemic stroke. Red blood cell fatty acids (RBC-FAs) are objective, long-term biomarkers of diet. In a case-control study nested in the European Prospective...
-
Diaz-Ponce AM, Campill S, Barbera M, Birck C, Soldevila-Domenech N, Forcano Gamazo L, Ayala-Garcia A, Mangialasche F, Bruinsma J, Zwan M, Hartmann T, De La Torre-Fornell R, Solomon A.
"This also matters to me": what does adherence to dementia risk reduction interventions mean to members of the public?
Aging clinical and experimental researchAbstractGrowing evidence highlights the potential of multidomain lifestyle-based interventions to reduce the risk of cognitive decline among older adults at higher risk of cognitive impairment. Within these...
-
Kac PR, González-Escalante A, Milà-Alomà M, Ashton NJ, Shekari M, Ortiz-Romero P, Turton M, Harrison P, Zetterberg H, Gispert JD, Karikari TK, Suárez-Calvet M, Blennow K.
Plasma p-tau212 identifies cognitively unimpaired individuals with emerging amyloid-β pathology
Journal of neurologyAbstractPlasma phosphorylated-tau (p-tau) biomarkers show high performance as first-in-line tests in the evaluation of patients with cognitive symptoms and have also found utility in clinical trials for anti...
-
Bollack A, Shekari M, Collij LE, Luckett E, García DV, Markiewicz P, Wolz R, Yaqub M, Wink AM, Gismondi R, Stephens A, Visser PJ, Mett A, Drzezga A, Buckley C, Gispert JD, Farrar G, Barkhof F.
Implementing robust amyloid PET quantification in multi-center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges
Alzheimer's & DementiaAbstractIntroduction: Amyloid-positron emission tomography (PET) is pivotal to Alzheimer's management, with the Centiloid standardizing measurements across tracers. AMYPAD trials (Diagnostic and Patient...
-
Porta-Mas C, Grau-Rivera O, Gispert JD, Blasco GS, Sánchez-Benavides G.
Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic review
Alzheimer's & DementiaAbstractDigital cognitive assessments have rapidly expanded in Alzheimer's disease (AD) research, offering a sensitive, scalable, and cost-effective alternative to traditional neuropsychological tests. This...
-
Valletta M, Briel N, Yuksekel I, Barboure M, Coward A, De Houwer JFH, Fawad A, González-Mayoral A, Iaccarino G, Martínez-Dubarbie F, Moukaled S, Andreasson U, Gobom J, Brinkmalm A, Tijms B, Zetterberg H, Blennow K, Suárez-Calvet M, Schöll M, Paterson RW, Montoliu-Gaya L, Sogorb-Esteve A.
Fluid biomarkers for neurodegenerative diseases: a comprehensive update
Alzheimer's Research & Therapy
